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Stable cell lines are able to express a foreign gene that has been inserted into the cell's genome. Expression of the exogenous gene is stable because its DNA is not floating outside of the chromosomes transiently but is instead permanently expressed within the genome. Stable cell lines are a powerful tool for expressing specific protein products on a production scale and have wide utility in molecular biology and biotechnology applications, including reporter gene assays (1) (2) (3) , cytokine assays (4), antibody production (5), and cellular screening for chemical compounds (1) or RNAi (6) . Mammalian cell lines such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), and human embryonic kidney (HEK293T) cells, have become the dominant systems (60%-70% proteins used) for producing recombinant protein pharmaceuticals for clinical use because they allow correct folding, assembly, and post-translational modifications of the recombinant proteins (7) .
To create a cell line that stably expresses a specific recombinant protein, an expression vector encoding the recombinant gene is typically transfected into a wild-type cell line, which then integrates, often randomly, into the host cell genome. To confer a selective advantage to the transgenic cells, another gene encoding a drug resistance protein or an essential metabolic enzyme is also introduced, either through co-transfection with another plasmid or placed together with the gene of interest (GOI) in the same vector using a dual-promoter or bicistronic construct. After transfection, selection pressure (e.g., antibiotics or essential amino acid-deficient medium) is applied to eliminate all untransfected wild-type cells. As a result, only the cells expressing the selectable marker gene (often wrongly assumed to be co-expressed effectively with the recombinant GOI) survive and grow into colonies in the culture vessel. Transgenes that are expressed transiently or integrated in multiple copies can lead to inconsistent and heterogeneous expression levels across cells. Thus, multiple rounds of single-cell isolation and expansion are required to ensure that a cell population stably expressing the transgene is obtained. Different independent cell clones need to be further verified through genotyping, sequencing, western blotting, and activity assays to ensure proper expression of a functional protein of interest.
Although these widely employed protocols are well-established and straightforward, they have numerous shortcomings. First, expression of the randomly integrated transgene can be difficult to control as it is often subject to the differential influences of its genomic surroundings, an issue known as position effect (8) (9) (10) . Second, Cell lines expressing foreign genes have been widely used to produce a variety of recombinant proteins. However, generating recombinant protein-expressing cell lines is usually a lengthy process and the resulting protein expression levels are often inconsistent. Here, we describe an efficient method for making stable cell lines expressing any recombinant protein of interest in a controllable and quantifiable manner. We integrate transgenes into specific genomic loci using CRISPR/Cas9 such that transgene expression is driven by endogenous promoters to ensure consistent and predictable expression of the recombinant protein. Expression levels can be predetermined by selecting promoters from genes with the desired level of expression. To quantify recombinant protein expression, a protein quantitation reporter (PQR) is incorporated between the endogenous and foreign genes. The PQR allows equimolar production of the endogenous protein, the recombinant protein, and a fluorescent reporter. As a result, expression levels of both the endogenous and recombinant proteins can be continuously monitored using fluorescence.
Reports

METHOD SUMMARY
A method for creating stable cell lines with built-in quantification of protein production is described. Using CRISPR/Cas9 genome editing, a gene of interest (GOI), along with a protein quantification reporter, is inserted into a specific genomic site. This preserves the host cell's genome integrity and facilitates the process of single cell clonal isolation while allowing the expression levels of the protein of interest to be monitored in single cells over time. the copy number of the integrated gene is often indeterminate and can vary from cell to cell, which often results in a heterogeneous cell population. Third, continuous selection pressure is required to maintain the transgene, as cells tend to remove randomly inserted foreign genetic elements that affect genome integrity. Some selective agents, such as antibiotics, cannot be fully neutralized by the encoded resistance markers, leading to accumulated mutations in the host cells (11) . These selection agents can be harmful and need to be removed from the purified recombinant proteins before being used in other applications. Such removal processes can be time-consuming and costly. Finally, the use of strong exogenous promoters, such as pCMV, often drives the expression of the recombinant gene at an elevated and non-physiological level (12) . Overexpression of recombinant proteins can place a considerable burden on host cells, especially when multiple copies of the transgene are inserted, which can then affect proper protein production.
Here, we present a new protocol for creating stable cell lines with locus-specific integration of transgenes, physiological and controllable expression of recombinant proteins, and the ability to quantify recombinant protein expression. Locus-specific integration and physiological expression can be achieved by placing the GOI under the control of an endogenous gene promoter through the use of the CRISPR/Cas9 geneediting technology. In addition, to allow for quantification of recombinant protein expression, a protein quantitation reporter (PQR) (13) is added to the transgene to enable equimolar production of the protein of interest and a fluorescent reporter molecule. Therefore, the fluorescence intensity of a cell can be used to quantify the expression of the protein of interest (13) .
A multicistronic gene cassette, PQR-RFPnols-PQR-GOI-PQR-Zeocin R (nols denotes nucleolar localization signal), was constructed and flanked by locus-specific homologous sequences in such a way that it can be incorporated into the target genomic locus through homologous recombination facilitated by CRISPR/Cas9. Moreover, only one copy of the gene cassette is inserted, under the control of an endogenous promoter while preserving all of the auxiliary regulatory elements, thus regulating gene expression through the targeted genomic loci. The preservation of the native genomic integrity and the physiological level of transgene expression minimize the burden imposed on the host cell, thereby ensuring permanent maintenance of the integrated transgene without the need for continuous selection pressure ( Figure 1A ).
Materials and methods
Construction of knock-in destination vectors
The genomic sequences of the human ribosomal protein L13A (RPL13A) and b actin (ACTB) genes were PCR-amplified from wild-type HEK293T cells. Human cell lines were chosen for validation in this study due to their broader applicability to other human cells, such as human induced pluripotent stem cells, but cell lines from other organisms could be used as well. The two protein quantitation reporters (PQRs) used here are optimized self-cleaving viral P2A peptides (13): P2A variant 2: 5´-GCGAC-GAATTTTAGTCTACTAAAACAAGCGGGT- 
Preparation of Cas9 and sgRNA expression vectors
Four different single guide RNAs (sgRNAs) were designed to guide the Cas9 nuclease to make a double-strand break at the end of the coding region of each gene (RPL13A and ACTB). They were designed in a 20 bp DNA oligonucleotide format as previously described (14) . Individual sgRNAs were cloned into the backbone of the dual promoter plasmid pX459-U6-Chimeric_ BB-CBh-hSpCas9-2A-Puro (Addgene #62988; www.addgene.org), such that both the sgRNA and Cas9 were expressed from the same vector. Different sgRNA/Cas9 vectors were co-transfected along with a circular RPL13A or ACTB destination vector into HEK293T cells using Lipofectamine 3000 (Thermo Fisher Scientific Inc., Waltham, MA). The efficiency of sgRNA/ Cas9-mediated integration of the destination vector into the genome was evaluated 5 days after transfection by cellular fluorescence and genotyping. The most efficient sgRNA sequences for RPL13A and ACTB are GCATTGTTGCCCTGGAATGTA and GACCTGGGCAGGTCGGCTGT, respectively. 
Image acquisition and analysis
Fluorescence and brightfield images were taken using a Zeiss AxioScope A1 fluorescence microscope (Carl Zeiss Canada Ltd., North York, Ontatrio, Canada). All images were acquired at 1388 × 1040 pixels with a 40× water objective, N.A. 1.0 (epifluorescence) corresponding to a 215 × 160 mm field of view. Fluorescence was detected using a charge-coupled device camera. All image acquisition parameters were fixed for each imaging channel for exposure time, excitation intensity, gain, and voltage.
Images were selected for analysis on the basis of identification of single cells with normal morphology. Images in figures were adjusted for contrast and brightness for presentation. Average fluorescence pixel intensities were measured by choosing a region of interest that covered 70% of the nuclei or the entire cell using ImageJ. Fluorescence pixel intensities were background subtracted and presented in arbitrary units.
Results and discussion
Identification of genomic loci for integration The first step of the protocol is to choose the appropriate genomic locus for integration ( Figure 1B ). The selection of genomic locus depends on several criteria: the intended level of expression, the required consistency of expression, and the preferred type of expression, such as inducible or constitutive. To express the protein of interest at easily detectable levels, we chose to express it from housekeeping genes.
Housekeeping genes are groups of genes that are responsible for the maintenance of cellular structure or homeostasis. Their expression levels are moderate to (physiologically) high and are often considered to be constant across experimental conditions and cell types. As a result, theses genes are widely used as reference genes in quantitative PCR and as loading controls in western blots. Numerous studies have been conducted to evaluate the consistency of expression of different housekeeping genes at the mRNA (15, 16) and protein levels (13, 17) . However, the nature of their expression in individual cells is still unclear. Here, we targeted a multicistronic gene cassette into two housekeeping gene loci, human ribosomal protein L13A (RPL13A) and b actin (ACTB), and measured the expression of the protein of interest and the corresponding housekeeping protein in single living cells (Figures 1 and 2) . ACTB has been shown to be the most highly expressed gene at both the mRNA and protein levels (17) . It is also one of the most widely used loading controls for western blot analysis. Expressing the transgene from the ACTB locus would not only achieve the maximum expression level of a protein of interest that can be attained, but it also gives us the opportunity to assess the consistency of ACTB expression across single cells, even when the population is derived from a single common progenitor cell. On the other hand, RPL13A has a moderate to high expression level (2) . As a ribosomal protein, the RPL13A level reflects the global transcription and translation level of a cell. In other words, RPL13A fluorescence intensity ( Figure 1D ) can indicate both the expression level of the recombinant protein and the global regulation of cellular homeostasis (18) .
Construction of a PQR multicistronic knock-in vector
Previously, we created multiple PQR constructs to allow for quantification over time of the protein production in single mammalian and insect cells (13) . The PQR genetic tag is transcribed with the GOI along with a fluorescent protein of choice. During protein synthesis, the protein of interest and the fluorescent protein are expressed in an equimolar ratio, and the two are immediately separated through self-cleavage of the PQR tag (13) . The fluorescence intensity of the cell is then used to quantify relative protein amounts, because the number of molecules of fluorescent protein is equal to the number of molecules of the protein of interest.
We constructed two destination vectors based on either the human RPL13A (Figure 
. Thus, red fluorescence intensity in the nucleolus is a measure of the expression levels of all the encoded proteins from either the RPL13A (Figure 1 ) or ACTB locus (Figure 2) . Zeocin R confers cell resistance to the antibiotic Zeocin, which induces cytotoxicity by binding to and cleaving DNA. The product of Zeocin R binds to Zeocin in a one-to-one ratio and prevents the DNA cleavage. Zeocin R was used as the selection marker owing to its relatively smaller size (375 bp versus 1 kb for the hygromycin resistance gene) and greater reliability in stable cell clone selection (19) . PQR linkers were cloned in frame between all of the encoding genes to split them into discrete proteins. To prevent vector recombination, different PQR tags with different synonymous codon compositions were used (see Materials and methods section). The flanking loxP sites may be used to remove the selection marker after the establishment of the stable cell line.
Generation of a stable and pure HEK293T cell line expressing a fluorescent reporter and a drug resistance protein Figure 2D) . RPL13A expressed at a lower but more consistent average level, whereas ACTB had a higher average expression level but showed greater expression heterogeneity among cells. The variability in expression levels of the two housekeeping genes among individual cells demonstrates the heterogeneous nature of single-cell gene expression. Genes expressed at high levels have larger variances in protein expression, for example in cells that secrete the immunoglobulin kappa light chain antibody protein (13) or even in cells from a monoclonal cell line. PQR can exploit this variability by selecting for a desired level of protein expression that can be identified using fluorescence intensity. These results suggest that for use as a reference gene for protein quantification across different cells, RPL13A has better accuracy for normalization. In contrast, if producing large quantities of recombinant protein is the primary goal, ACTB would be a better choice.
The correct stable knock-in cell clones were verified by PCR genotyping with one primer recognizing the genomic region outside the homology arm and the other primer within the RFP or Zeocin R sequence ( Figure 1C and Figure 2B ). Amplified PCR products were verified by Sanger sequencing (Supplementary Material). These results suggest that RFPnols and Zeocin were correctly co-expressed and functionally active in the selected stable cell clones.
A stable cell line expressing a protein of interest at quantifiable levels We demonstrated that the correct knock-in of PQR-RFPnols-PQR-Zeocin R at both RPL13A and ACTB loci confers Zeocin resistance to the cells with red fluorescent nucleoli. Next, we wanted to demonstrate the ease and advantages of expressing proteins of interest using this method of stable cell line generation. As a proof of principle experiment, we chose GFP with a nucleolar localization signal (GFPnols) as a representative protein of interest because green fluorescence in the nucleoli is a simple and quantitative phenotype. An accompanying RFP reporter (cytoplasmic) was used to measure both ACTB and GFPnols expression. A destination vector with the recombinant gene, PQR-RFP-PQR-GFPnols-PQR-loxPZeocin R -loxP, was constructed and transfected into HEK293T cells along with the ACTB CRISPR/Cas9 reagent ( Figure 3A) . Correlation between red and green fluorescence intensities was then used to validate the hypothesis that the expression of the recombinant protein is reliably measured using fluorescence ( Figure 3D ).
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Following the same protocol, the ACTB stable cell line expressing the GFPnols was created within the same amount of time as the previous experiments ( Figure 1A ). RFP and GFP were expressed and localized to their respective cellular compartments ( Figure 3C ), and the red and green fluorescence signals were correlated with a coefficient of determination (R 2 ) of 0.79 ( Figure 3D ). This confirms that the production of any protein of interest can be quantified on the basis of the fluorescent reporter output of a cell and that any resulting cellular phenotype can be correlated as a function of protein concentration (13) . This also demonstrates that four proteins: the endogenous protein (ACTB), the fluorescent reporter (RFP), the protein of interest (GFPnols), and the drug resistance protein (Zeocin R ), can be effectively expressed without compromising their native functions ( Figure 3C ).
Compared with the traditional protocol for the creation of stable cell lines, our new protocol has numerous advantages. First, integration of the transgene into a predetermined locus so that it is driven by an endogenous promoter provides the opportunity to predict and control the level of recombinant protein expression. This is impossible when the recombinant gene is driven by an exogenous promoter and is integrated randomly into the genome in multiple copies. Second, the precise targeting of the transgene to the intended locus through CRISPR/Cas9 can obviate the time-consuming characterization of the isolated cell clones, shortening the selection process to 2-3 weeks as opposed to several months when a traditional random integration-based method is used ( Figure  1A) . Third, the selected homogeneous knock-in cell lines can be maintained without continuous selection pressure. This is particularly beneficial since Zeocin cannot be fully neutralized by the product of the Zeocin R gene (11) . Chronic exposure to Zeocin during a prolonged selection process has been shown to cause mutagenesis in the established recombinant cell lines (11) . We verified that all cells maintained their fluorescence intensities for >15 passages after removal of the Zeocin selection. Fourth, the obtained knock-in HEK293T cells have comparable growth rates and morphologies as their wild-type counterparts, suggesting that the physiological levels of expression of RFP and GFP as well as Zeocin R do not exert too much stress on the host cells. The preservation of native cellular phenotypes and molecular processes is particularly beneficial, as any impairment of normal cellular physiology would be considered undesirable when it comes to experiments such as drug screening, gene function studies, and other applications in which a normal homeostatic cellular milieu is needed. In contrast, when the transgene is driven by an exogenous promoter and integrated into the genome in multiple copies, overexpression of the recombinant protein or disruption of the genome can cause unwanted side effects, leading to incorrect interpretation of the experimental results. Finally, the accompanying RFP or other PQR fluorescent reporter provides the opportunity to quantify recombinant protein expression under conditions in which the level of RPL13A or ACTB housekeeping gene expression can be stable or experimentally manipulated. 
